Aleafia Health Appoints Finance Executive Matt Sale as Chief Financial Officer
TORONTO, June 21, 2021 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, is pleased to announce the appointment of Matt Sale to its executive leadership team as chief financial officer, effective today.
Mr. Sale is a proven finance professional who brings over 15 years of progressively more senior leadership roles and accomplishments to Aleafia Health. Working within the investment banking groups of Raymond James and BMO Capital Markets, he has been a trusted financial advisor to some of Canada’s most prominent publicly listed and private companies, helping execute their growth strategy, equity and debt financing transactions, and mergers & acquisitions.
“We are delighted to have Matt join Aleafia Health as we continue to rapidly scale our cannabis wellness ecosystem and capture market share in adult-use, medical and international cannabis markets,” said Aleafia Health CEO Geoffrey Benic. “His proven track record of delivering shareholder value through accretive acquisitions and his roll-up-the-sleeves approach to financial management will serve us incredibly well.”
Matt holds a Bachelor of Commerce from the University of Toronto, earned his Master of Business Administration from the Rotman School of Management at the University of Toronto and is a Chartered Professional Accountant.
“Having followed Aleafia Health’s growth over recent years, I am thrilled to be joining it at such an exciting time. I have been impressed with the best-in-class cultivation and manufacturing facilities, and its innovative product portfolio which continues to capture market share,” said Mr. Sale. “I look forward to working with the team to build on the strong foundation already laid, and capturing the tremendous market opportunity that lies before us.”
For Investor & Media Relations:
Nicholas Bergamini, VP Investor Relations
LEARN MORE: www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and with sales and operations in Australia and Germany. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.
Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips, and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.
Forward Looking Information
This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.